{"id":"W2762226752","doi":"10.1200/jco.2017.75.4648","title":"Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":398,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"American Society of Clinical Oncology; Gilead Sciences; Bayer","keywords":"Medicine; Internal medicine; Adverse effect; Lymphoma; Phases of clinical research; Gastroenterology; Refractory (planetary science); Oncology; Phosphatidylinositol; Progression-free survival; Chemotherapy; Kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002997643,0.0002099984,0.0004990068,0.0002318389,0.0001786806,0.0002678534,0.0001971367,0.00013,0.0004914702],"category_scores_gemma":[0.0002322854,0.00006196003,0.0001937072,0.0002239096,0.0001729699,0.0001364677,0.0001282714,0.0003331476,0.0001077929],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005545497,"about_ca_system_score_gemma":0.0002944087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006338276,"about_ca_topic_score_gemma":0.001881732,"domain_scores_codex":[0.9999053,0.0000308051,0.000007558554,0.00001443126,0.00001903339,0.00002277104],"domain_scores_gemma":[0.999913,0.00001633269,0.00002939197,0.000006395851,0.000005927398,0.00002887116],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.03119695,0.004973048,0.1148955,0.000841858,0.0004472451,0.002793783,0.0003363638,0.006476524,0.2839159,0.0004562957,0.004042294,0.5496241],"study_design_scores_gemma":[0.02549101,0.164096,0.5816103,0.0002440338,0.001249787,0.01225495,0.0004209142,0.03615448,0.1531029,0.001163608,0.02413255,0.0000793346],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967521,0.002204365,0.0002062851,0.00005184725,0.000005911146,0.00004491951,0.0000592613,0.00002994231,0.0006453482],"genre_scores_gemma":[0.9985611,0.0006549138,0.0003464682,0.00008576642,0.00001264682,0.00004108596,0.0001083256,0.000003021582,0.0001866461],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006338276,"threshold_uncertainty_score":0.004023552,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1107853068996512,"score_gpt":0.4613984961863448,"score_spread":0.3506131892866936,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}